Prakt. lékáren. 2015; 11(1): 8-12

Oropharyngeal candidiasis

Jan Hašek
Lékárna U Matky Boží, Doksy

Oropharyngeal candidiasis is a typical opportunistic infection of the oral mucous membrane and the pharynx, most commonly caused

by the yeast Candida albicans. Being manifested only rarely in healthy adults, the condition is much more common in infants and young

children, the elderly, and, in particular, immunocompromised patients. The article presents the basic types of the disease and provides

an overview of the medications used. Based on international guidelines, attention is paid to the management strategies in children and

adults with no serious disorder of the immune system.

Keywords: oropharyngeal candidiasis, Candida albicans, azole antifungals, nystatin, guidelines

Published: February 26, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hašek J. Oropharyngeal candidiasis. Praktické lékárenství. 2015;11(1):8-12.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Candida - oral - NICE CKS. Dostupné na území Velké Británie: cks.nice.org.uk/candida-oral.
    2. Caroline L Pankhurst. Candidiasis (oropharyngeal). Clin Evid (Online). 2009(18): 1304.
    3. Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med. 2000; 11(2): 172-198. Go to original source... Go to PubMed...
    4. Vazquez JA. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl). 2010; 2: 89-101. Go to original source... Go to PubMed...
    5. Sklenář Z, Ščigel Š. Magistraliter receptura ve stomatologii. Praha: 2013. Havlíček Brain Team.
    6. Laurent M, Gogly B, Tahmasebi F, Paillaud E. Oropharyngeal candidiasis in elderly patients. Geriatr Psychol Neuropsychiatr Vieil. 2011; 9(1): 21-28. Go to original source... Go to PubMed...
    7. Deutscher Arzneimittel-Codex (DAC) 2007/Neues Rezeptur-Formularium (NRF). Band I-III. Pharmazeutischen Laboratorium des NRF. Eschborn: Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2007.
    8. Dortová E, Dort J. Kožní a slizniční kandidóza u novorozence a kojence. Pediatr. praxi, 2012; 13(3): 153-154.
    9. Hoppe JE, Hahn H. Randomized comparison of two nystatin oral gels with miconazole oral gel for treatment of oral thrush in infants. Antimycotics Study Group. Infection 1996; 24(2): 136-139. Go to original source... Go to PubMed...
    10. Hoppe JE. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. The Antifungals Study Group. Pediatr Infect Dis J 1997; 16(3): 288-293. Go to original source... Go to PubMed...
    11. European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole. Dostupné na http://www.ema.europa.eu/ema/ Datum náhledu 14.12.2014.
    12. Pappas PG, et al. Clinical practice guidelines for the mana gement of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48(5): 503-535. Go to original source... Go to PubMed...
    13. Hašek J. Nové léčivé látky v magistraliter receptuře XIV - mikonazol a mikonazol-nitrát. Prakt. lékáren. 2013; 9(4-5): 192-195.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.